The role of modelling in the policy decision making process for cancer screening: example of prostate specific antigen screening

by Abraham M Getaneh, Eveline AM Heijnsdijk, Harry J de Koning
Published 2019-07-01

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model...

by Abraham M. Getaneh, Eveline AM Heijnsdijk, Harry J. deKoning
Published 2021-06-01

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study

by Abraham M. Getaneh, Eveline A. M. Heijnsdijk, Harry J. de Koning
Published 2021-01-01

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.

by Amir-Houshang Omidvari, Iris Lansdorp-Vogelaar, Harry J de Koning, Reinier G S Meester
Published 2021-01-01

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the...

by Kevin ten Haaf, Harry J de Koning, Erik F Blom, Douglas A Arenberg
Published 2020-05-01

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

by Abraham M. Getaneh, Eveline A. M. Heijnsdijk, Monique J. Roobol, Harry J. deKoning
Published 2020-10-01

Screening for cancers with a good prognosis: The case of testicular germ cell cancer

by Eveline A. M. Heijnsdijk, Steven J. Supit, Leendert H. J. Looijenga, Harry J. deKoning
Published 2021-04-01

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk

by H. Amarens Geuzinge, Eveline A.M. Heijnsdijk, Inge-Marie Obdeijn, Harry J. de Koning, Madeleine M.A. Tilanus-Linthorst
Published 2021-04-01

Have preferences of girls changed almost 3 years after the much debated start of the HPV vaccination program in The Netherlands? A discrete choice experiment.

by Robine Hofman, Esther W de Bekker-Grob, Jan Hendrik Richardus, Harry J de Koning, Marjolein van Ballegooijen, Ida J Korfage
Published 2014-01-01

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study

by Eveline A. M. Heijnsdijk, Marcell Csanádi, Andrea Gini, Kevin tenHaaf, Rita Bendes, Ahti Anttila, Carlo Senore, Harry J. de Koning
Published 2019-10-01

Automated coronary artery calcification scoring in non-gated chest CT: agreement and reliability.

by Richard A P Takx, Pim A de Jong, Tim Leiner, Matthijs Oudkerk, Harry J de Koning, Christian P Mol, Max A Viergever, Ivana Išgum
Published 2014-01-01

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios

by Nadine Zielonke, Amarens Geuzinge, Eveline A. M. Heijnsdijk, Sirpa Heinävaara, Carlo Senore, Katja Jarm, Harry J. de Koning, Nicolien T. van Ravesteyn, on behalf of the EU-TOPIA Consortium
Published 2021-07-01

Interpretation and adherence to the updated risk-stratified guideline for colonoscopy surveillance after polypectomy – a nationwide survey

by Miriam P. van der Meulen, Ida J. Korfage, Else-Mariëtte B. van Heijningen, Harry J. de Koning, Monique E. van Leerdam, Evelien Dekker, Iris Lansdorp-Vogelaar
Published 2020-09-01

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

by Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza
Published 2020-09-01

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

by Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza
Published 2017-04-01

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

by Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat
Published 2017-02-01

Impact of cardiovascular calcifications on the detrimental effect of continued smoking on cardiovascular risk in male lung cancer screening participants.

by Pushpa M Jairam, Pim A de Jong, Willem P T h M Mali, Ivana Isgum, Harry J de Koning, Carlijn van der Aalst, Matthijs Oudkerk, Rozemarijn Vliegenthart, Yolanda van der Graaf
Published 2013-01-01

Modeling the natural history of ductal carcinoma in situ based on population data

by Sarocha Chootipongchaivat, Nicolien T. van Ravesteyn, Xiaoxue Li, Hui Huang, Harald Weedon-Fekjær, Marc D. Ryser, Donald L. Weaver, Elizabeth S. Burnside, Brandy M. Heckman-Stoddard, Harry J. de Koning, Sandra J. Lee
Published 2020-05-01

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe

by Andrea Gini, Maaike Buskermolen, Carlo Senore, Ahti Anttila, Dominika Novak Mlakar, Piret Veerus, Marcell Csanádi, Erik E. L. Jansen, Nadine Zielonke, Sirpa Heinävaara, György Széles, Nereo Segnan, Harry J. de Koning, Iris Lansdorp-Vogelaar
Published 2021-01-01

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.

by Suzette M Matthijsse, Steffie K Naber, Jan A C Hontelez, Roel Bakker, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Inge M C M de Kok, Harry J de Koning, Joost van Rosmalen, Sake J de Vlas
Published 2018-01-01